Clinical trial
Efficacy and Safety of an Antiviral Polymeric Nasal Spray: A Randomized, Parallel Group, Double-blind, Placebo-controlled Study in Subjects With Early Symptoms of Common Cold
NCT01488604 is registered in ClinicalTrials.gov with McNeil AB as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of an Antiviral Polymeric Nasal Spray: A Randomized, Parallel Group, Double-blind, Placebo-controlled Study in Subjects With Early Symptoms of Common Cold
- Lead sponsor
- McNeil AB
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2012
- Completion date
- May 31, 2012
- Enrollment
- 163 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.